ASCO CancerLinQ®

ASCO CancerLinQ®

CancerLinQ® Connects Oncologists with Patient Data for Better Treatment Decisions

Individualized cancer care is very complex. Evidence-based standards of care are the foundation for cancer treatment; however, the unique medical presentation of each oncology patient—from genetic variations to concurrent health conditions—creates challenges for healthcare providers as they prescribe treatment options. When treatment decisions need to be made, access to comparative information in a normalized format can transform the quality of care and outcomes a cancer patient may experience.

CancerLinQ® was created to give oncology treatment specialists better tools to understand and manage cancer care.

CancerLinQ® aims to improve cancer care with the power of real-time treatment data and analytics. To ensure that CancerLinQ® can access, acquire and analyze any type of data from EHR systems, CancerLinQ LLC chose the Jitterbit Healthcare Interoperability Platform to bring together and transform data from all of these sources. Working closely with CancerLinQ LLC, Jitterbit developed an intelligent way to accurately process and transform healthcare data from any source to a single common format that CancerLinQ® member practices and researchers can understand.

“Jitterbit is really providing a valuable service to CancerLinQ®. The heart of CancerLinQ® is bringing information and data from our participating practices into the CancerLinQ® platform and Jitterbit is at the front lines of doing that.”

– Rich Ross, Chief Operations Officer, CancerLinQ LLC

Thousands of oncology physicians and researchers throughout the country can access and contribute to a robust and current data repository of clinical data. The system employs data ingestion and analytics tools, providing outcomes information for specific cancer types and treatment regimens.

Electronic health record (EHR) interoperability has long been a significant problem for the medical industry impacting patient safety, treatment outcomes and the overall efficiency of healthcare providers. The CancerLinQ® project takes on many unique interoperability challenges. Each clinician member or physician group participating in CancerLinQ® may use different or multiple EHRs as well as practice management systems (PMS) and document medical data in varying forms and formats. Valuable medical information can be observed as structured data within an EHR as well as in an unstructured presentation such as scanned documents or transcribed physician notes.

As with all medical data, the CancerLinQ® project manages and maintains protected health information (PHI) in strict accordance to HIPAA requirements. Jitterbit makes this possible by processing data on agents that reside behind member practices’ firewalls and provide complete protection while securely encrypting the data.

A CancerLinQ® requirement for data interoperability processes is to require minimal IT involvement from the participating practice sites. Jitterbit is able to meet this need by implementing its data solution with a rapid, seamless and secure approach. The Jitterbit model to enable remote monitoring of the practices CancerLinQ IT functions, and the secure acquisition and data modeling to prepare information for analytical use, has been well received by the ASCO team.

With the Jitterbit Healthcare Interoperability Platform in place, CancerLinQ® member physicians can now access thousands of cancer cases that may share the characteristics of their own patients. Cancer professionals participating in the CancerLinQ® initiative have quick access to a vast amount of detailed data to use in large-scale analysis. The ability to acquire treatment outcomes for various cancer diagnoses and drug regimens used for varying demographics characteristics, including genetic profile, aids clinicians with real-time decision making.

Since connecting practices with the Jitterbit Healthcare Interoperability Platform, CancerLinQ LLC is able to accelerate the process of connecting new CancerLinQ members and process more data, all without requiring members to invest significant internal IT resources. Jitterbit provides the right clinical information in the right format at the right time, so oncologists can make more informed decisions about cancer care and ultimately improve outcomes for oncology patients nationally.

Company

ASCO’s CancerLinQ®

About

CancerLinQ LLC, a wholly-owned nonprofit of the American Society of Clinical Oncology (ASCO) assembles vast amounts of searchable, real-world, clinical cancer data into a powerful database, called CancerLinQ, to enable quality, personalized cancer care for every patient.

Industry

Healthcare

Challenges

  • Oncologists need fast access to vast amounts of data to improve patient care
  • Oncology practices store data in various formats in different EHR and PMS systems, making it difficult to access and analyze data
  • Both structured and unstructured data needs to be available for analysis
  • Oncology practices often have limited IT resources and need to be able to get value from the platform quickly with minimal time investment

  • CancerLinQ® data needs to be shared and secured in accordance with HIPAA requirements

Successes

  • Connects individual oncology practices using different proprietary systems, including, but not limited to, MOSAIQ (Elekta), Aria (Varian), EPIC (including Beacon) and AllScripts
  • Brings together unstructured data with structured data in multiple standard formats
  • Receives data from proprietary EHR systems, standardizes common data and automates complex data transformations to enable comprehensive analysis
  • Requires small software footprint and minimal IT resources
  • Includes scalable method for managing health data integrations remotely
  • Keeps data secure at all points in the process
  • Contextualizes various diagnostic information (including genomic data), treatment and patient assessment criteria across patient demographics
  • Provides the right data at the right time to enable better patient care